專業測試市場——增長、趨勢、COVID-19 的影響、預測 (2023-2028)

在預測期內，專業測試市場預計將以 12% 的複合年增長率增長。

市場增長的主要驅動力是傳染病和罕見病等病例的增加。 據歐盟委員會稱，歐洲地區約有 27 至 3600 萬人受到罕見病的影響。 根據疾病控制和預防中心的數據，2017 年大約有 54,285 例沙門氏菌病例。 因此，這種日益增加的罕見疾病負擔預計將在預測期內增加對專業檢測市場增長的需求。

專項檢測市場趨勢

市場細分預計在預測期內將出現顯著的市場增長

預計在預測期內，腫瘤學在專業檢測市場將呈現健康增長。 癌症早期診斷和治療的重要性日益增加，將對該領域的市場增長產生積極影響。 據世界衛生組織稱，癌症是全球第二大死因之一。 2018 年，全球報告了約 180 萬例新癌症病例。 最常見的癌症類型是肺癌、乳腺癌和前列腺癌。

此外，研發活動投資的增加預計將推動測試需求。 根據歐洲製藥工業協會聯合會的數據，2017年全球製藥行業整體銷售額約為8526.47億美元。 因此，上述因素有望推動該領域的市場增長。

預計北美將佔據很大的市場份額，預計在預測期內也會如此

由於研發活動和投資的增加，預計北美將成為專業測試市場的主導地區。 根據國家罕見病組織的數據，大約有 3000 萬人患有某種形式的疾病（2019 年）。 近十分之一的美國人患有罕見病，其中一半以上是兒童。 根據美國研究與製藥商協會的數據，2018 年美國生物製藥公司的研發支出約為 796 億美元。 因此，由於罕見疾病負擔的增加和研發活動投資的增加，預計對專業測試的需求將推動該地區的市場增長。

專業檢測市場競爭分析

在專業測試市場運營的知名公司包括 American Esoteric Laboratories、Quest Diagnostics、Laboratory Corporation of America、bioMontr Labs、Arup Laboratories、Miraca Holdings Inc、Fulgent Genetics Inc、Nordic Laboratories 和 Grifols, S.A. 等。

其他好處

• Excel 格式的市場預測 (ME) 表
• 三個月的分析師支持

內容

第一章介紹

• 調查先決條件
• 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

• 市場概覽
• 市場驅動力
  • 增加慢性病負擔
  • 罕見病增加
  • 研發費用增加
• 市場製約因素
  • 嚴格的監管框架
• 波特的五力分析
  • 新進入者的威脅
  • 買方/消費者議價能力
  • 供應商的議價能力
  • 替代品的威脅
  • 競爭公司之間的敵對關係

第 5 章市場細分

• 按測試類型
  • 內分泌學
  • 感染
  • 腫瘤科
  • 神經學
  • 毒理學
  • 其他
• 按技術
  • 流式細胞術
  • 化學發光免疫分析
  • 質譜
  • 放射免疫分析
  • 其他
• 按地區
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 中東和非洲
    • 海灣合作委員會
    • 南非
    • 其他中東和非洲地區
  • 南美洲地區
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章競爭格局

• 公司簡介
  • American Esoteric Laboratories
  • Arup Laboratories
  • bioMontr Labs
  • Fulgent Genetics Inc.
  • Grifols, S.A.
  • Laboratory Corporation of America
  • Miraca Holdings Inc.
  • Nordic Laboratories
  • Quest Diagnostics

第7章 市場機會今後動向

The esoteric testing market is expected to register a 12 % of CAGR over the forecast period. The key contributors in the market growth are rising cases of infectious and rare diseases and other diseases. According to the European Commission, approximately 27 to 36 million people suffer from rare disease in European region. Also, according to the Centre for Disease Control and Prevnetion, 2017, the number of cases of salmonella were around 54,285. Hence this growing burden of rare diseases is expected to increase the demand for esoteric testing market growth during the forecast period.

Esoteric Testing Market Trends

Oncology Segment is Expected to Exhibit a Significant Market Growth Over the Forecast Period

Oncology is expected to show a healthy growth in the Esoteric Testing Market during the forecast period. The rising importance of early diagnosis and treatment for cancer will impact positively on the market growth in this segment. According to the World Health Organization, cancer is one of the second leading cause of death worldwide. In 2018, around 1.8 million new cases were reported with cancer globally. The most common type of cancers are lung, breast and prostate cancer.

Furthermore, the increasing investments of R&D activities is expected to drive the demand of testing. According to the European Federation of Pharmaceutical Industries and Associations, 2017, the overall sales of pharmaceutical industry worldwide was recorded to be approximately 852,647 million USD. Hence, the aforementioned factors are expected to boost the market growth in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the Esoteric Testing market owing to increasing number of R&D activities and investments on it. As per the data of National Organization of Rare Diseases, around 30 million people were suffering from some type of diseases (2019). Also, almost one out of ten individuals in America have rare diseases and more than half of these are children. According to the Pharmaceutical Research & Manufacturers of America, in 2018, the R&D expenditure by biopharmaceutical companies was around 79.6 billion USD in United States. Thus, with growing burden of rare diseases and increasing investment into research and development activities the demand for esoteric testing is expected to propel the market growth in this region.

Esoteric Testing Market Competitive Analysis

Some of the well-known companies that are operating in Esoteric Testing market include American Esoteric Laboratories, Quest Diagnostics, Laboratory Corporation of America, bioMontr Labs, Arup Laboratories, Miraca Holdings Inc., Fulgent Genetics Inc., Nordic Laboratories and Grifols, S.A.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Burden of Chronic Diseases
  • 4.2.2 Rising Cases of Rare Diseases
  • 4.2.3 Increasing Spending in Research & Development Activities
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulatory Framework
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Test Type
  • 5.1.1 Endocrinology
  • 5.1.2 Infectious Disease
  • 5.1.3 Oncology
  • 5.1.4 Neurology
  • 5.1.5 Toxicology
  • 5.1.6 Others
• 5.2 By Technology
  • 5.2.1 Flow Cytometry
  • 5.2.2 Chemiluminescence Immunoassay
  • 5.2.3 Mass Spectrometry
  • 5.2.4 Radio Immunoassay
  • 5.2.5 Others
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 American Esoteric Laboratories
  • 6.1.2 Arup Laboratories
  • 6.1.3 bioMontr Labs
  • 6.1.4 Fulgent Genetics Inc.
  • 6.1.5 Grifols, S.A.
  • 6.1.6 Laboratory Corporation of America
  • 6.1.7 Miraca Holdings Inc.
  • 6.1.8 Nordic Laboratories
  • 6.1.9 Quest Diagnostics

7 MARKET OPPORTUNITIES AND FUTURE TRENDS